PD 115934

Drug Profile

PD 115934

Alternative Names: NSC 366140; Pyrazoloacridine; PZA

Latest Information Update: 25 Sep 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pfizer
  • Developer National Institutes of Health (USA); Pfizer
  • Class Acridines; Pyrazoles; Small molecules
  • Mechanism of Action RNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer; Colorectal cancer; Endometrial cancer; Ovarian cancer; Pancreatic cancer; Renal cancer

Most Recent Events

  • 25 Sep 2006 Discontinued - Phase-I for Cancer in USA (unspecified route)
  • 25 Sep 2006 Discontinued - Phase-II for Colorectal cancer in USA (IV-infusion)
  • 25 Sep 2006 Discontinued - Phase-II for Endometrial cancer in USA (IV-infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top